CRINETICS PHARMACEUTIC
59.81
07-November-24 15:59:58
15 minutes delayed
Stocks
+0.65
+1.10%
Today's range
58.66 - 60.17
ISIN
N/A
Source
NASDAQ
-
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
20 Oct 2021 16:01:37 By Nasdaq GlobeNewswire
-
18 Oct 2021 16:00:00 By Nasdaq GlobeNewswire
-
27 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in September Investor Conferences
07 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
02 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
10 Aug 2021 16:02:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces $15.0 Million Private Placement with Frazier Healthcare Partners
29 Jul 2021 07:30:00 By Nasdaq GlobeNewswire
-
28 Jun 2021 07:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Appoints Garlan Adams as General Counsel
16 Jun 2021 08:30:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
06 May 2021 16:05:02 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Closing of Common Stock Offering
12 Apr 2021 16:05:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
07 Apr 2021 18:31:23 By Nasdaq GlobeNewswire
-
30 Mar 2021 16:05:00 By Nasdaq GlobeNewswire
-
24 Mar 2021 07:10:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Pipeline Progress on Display at ENDO 2021
22 Mar 2021 07:10:00 By Nasdaq GlobeNewswire
-
12 Mar 2021 07:10:00 By Nasdaq GlobeNewswire
-
04 Feb 2021 07:10:00 By Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study
03 Feb 2021 07:10:00 By Nasdaq GlobeNewswire